Intuitive Surgical, Inc. Stock Sao Paulo

Equities

I1SR34

BRI1SRBDR001

Advanced Medical Equipment & Technology

Market Closed - Sao Paulo 15:30:11 2024-06-21 EDT 5-day change 1st Jan Change
118.3 BRL +0.62% Intraday chart for Intuitive Surgical, Inc. +3.39% +44.57%

Financials

Sales 2024 * 8.03B 43.77B 11B Sales 2025 * 9.33B 50.83B 12.77B Capitalization 153B 836B 210B
Net income 2024 * 1.97B 10.72B 2.69B Net income 2025 * 2.27B 12.39B 3.11B EV / Sales 2024 * 18.5 x
Net cash position 2024 * 5.19B 28.31B 7.11B Net cash position 2025 * 7.75B 42.26B 10.62B EV / Sales 2025 * 15.6 x
P/E ratio 2024 *
79.1 x
P/E ratio 2025 *
68.3 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.62%
1 week+3.39%
Current month+13.03%
1 month+13.93%
3 months+20.47%
6 months+45.08%
Current year+44.57%
More quotes
1 week
115.30
Extreme 115.3
120.25
1 month
103.30
Extreme 103.3
120.25
Current year
78.87
Extreme 78.87
120.25
1 year
64.37
Extreme 64.37
120.25
3 years
48.02
Extreme 48.02
120.25
5 years
39.21
Extreme 39.2083
120.25
10 years
39.21
Extreme 39.2083
120.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 66 07-10-18
Director/Board Member 71 10-03-31
More insiders
Date Price Change Volume
24-06-21 118.3 +0.62% 5,408
24-06-20 117.6 -2.16% 1,554
24-06-19 120.2 +1.80% 148
24-06-18 118 +2.37% 1
24-06-17 115.3 +0.77% 1

Delayed Quote Sao Paulo, June 21, 2024 at 03:30 pm

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
432.6 USD
Average target price
426.5 USD
Spread / Average Target
-1.40%
Consensus